Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology

DSpace/Manakin Repository

Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology
 
Jaarsma, T; Hill, L; Bayes-Genis, A; Brunner La Rocca, H P; Castiello, T; Čelutkienė, J; Marques-Sule, E; Plymen, C M; Piper, S E; Riegel, B; Rutten, F H; Ben Gal, T; Bauersachs, J; Coats, Ajs; Chioncel, O; Lopatin, Y; Lund, L H; Lainscak, M; Moura, B; Mullens, W; Piepoli, M F; Rosano, G; Seferovic, P; Strömberg, A
(2021) European Journal of Heart Failure, volume 23, issue 1, pp. 157 - 174
(Article)
Abstract
Self-care is essential in the long-term management of chronic heart failure. Heart failure guidelines stress the importance of patient education on treatment adherence, lifestyle changes, symptom monitoring and adequate response to possible deterioration. Self-care is related to medical and person-centred outcomes in patients with heart failure such as better quality ... read more
Download/Full Text
Open Access version via Utrecht University Repository Publisher version
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Heart failure, Lifestyle, Patient education, Self-care, Cardiology and Cardiovascular Medicine, Journal Article
DOI: https://doi.org/10.1002/ejhf.2008
ISSN: 1388-9842
Publisher: Oxford University Press
Note: Funding Information: : L.H. reports personal fees from Novartis, outside the submitted work. A.B.G. reports personal fees from Abbott, Novartis, Vifor Pharma, during the conduct of the study; grants from Roche Diagnostics, personal fees from Critical Diagnostics, AstraZeneca, outside the submitted work. H.P.B.L.R. reports grants and personal fees from Vifor Pharma, Novartis. J.C. reports personal fees from Novartis, Servier, Grindex, Boehringer Ingelheim, AstraZeneca; grants from Roche Diagnostics, outside the submitted work. C.M.P. reports personal fees from Novartis, Vifor Pharma, outside the submitted work. S.E.P. reports personal fees from Novartis, AstraZeneca, Vifor Pharma, outside the submitted work. J.B. reports personal fees from Novartis, BMS, Pfizer, Bayer, Servier, MSD, Boehringer Ingelheim, AstraZeneca, Abbott, Medtronic, Daichii Sankyo; grants and personal fees from Vifor, CvRX, Abiomed, Zoll, outside the submitted work. A.J.S.C. reports personal fees from AstraZeneca, Bayer, Boehringer Ingelhiem, Menarini, Novartis, Nutricia, Servier, Vifor, Actimed, Arena, Cardiac Dimensions, Corvia, CVRx, Enopace, ESN Cleer, Faraday, Gore, Impulse Dynamics, Respicardia, outside the submitted work. O.C. reports grants from Servier, Novartis, Vifor, other from Boehringer, outside the submitted work. L.H.L. reports personal fees from Merck, Sanofi, Bayer, Pharmacosmos, Abbott, Medscape, Myokardia; grants and personal fees from Vifor‐Fresenius, AstraZeneca, Relypsa, Novartis, Mundipharma, Boehringer Ingelheim; grants from Boston Scientific, outside the submitted work. M.L. reports personal fees from Vifor‐Fresenius, AstraZeneca, Relypsa, Bayer, Novartis, Boehringer Ingelheim, outside the submitted work. The other authors have nothing to disclose. Conflict of interest Funding Information: We would like to thank Richard Mindham, member of the ESC Patient Forum for his comments and suggestions for this paper. Conflict of interest: L.H. reports personal fees from Novartis, outside the submitted work. A.B.G. reports personal fees from Abbott, Novartis, Vifor Pharma, during the conduct of the study; grants from Roche Diagnostics, personal fees from Critical Diagnostics, AstraZeneca, outside the submitted work. H.P.B.L.R. reports grants and personal fees from Vifor Pharma, Novartis. J.C. reports personal fees from Novartis, Servier, Grindex, Boehringer Ingelheim, AstraZeneca; grants from Roche Diagnostics, outside the submitted work. C.M.P. reports personal fees from Novartis, Vifor Pharma, outside the submitted work. S.E.P. reports personal fees from Novartis, AstraZeneca, Vifor Pharma, outside the submitted work. J.B. reports personal fees from Novartis, BMS, Pfizer, Bayer, Servier, MSD, Boehringer Ingelheim, AstraZeneca, Abbott, Medtronic, Daichii Sankyo; grants and personal fees from Vifor, CvRX, Abiomed, Zoll, outside the submitted work. A.J.S.C. reports personal fees from AstraZeneca, Bayer, Boehringer Ingelhiem, Menarini, Novartis, Nutricia, Servier, Vifor, Actimed, Arena, Cardiac Dimensions, Corvia, CVRx, Enopace, ESN Cleer, Faraday, Gore, Impulse Dynamics, Respicardia, outside the submitted work. O.C. reports grants from Servier, Novartis, Vifor, other from Boehringer, outside the submitted work. L.H.L. reports personal fees from Merck, Sanofi, Bayer, Pharmacosmos, Abbott, Medscape, Myokardia; grants and personal fees from Vifor-Fresenius, AstraZeneca, Relypsa, Novartis, Mundipharma, Boehringer Ingelheim; grants from Boston Scientific, outside the submitted work. M.L. reports personal fees from Vifor-Fresenius, AstraZeneca, Relypsa, Bayer, Novartis, Boehringer Ingelheim, outside the submitted work. The other authors have nothing to disclose. Publisher Copyright: © 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
(Peer reviewed)